Ajooni Biotech Limited has informed the Exchange regarding 'Intimation regarding commencement of commercial production at newly installed manufacturing facilities and receipt of new orders of Rs. 27 Crores'.
AJOONI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.9 pts more than Nifty Microcap 250 and 2.8 pts more than its Food Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Ajooni Biotech has started commercial production at its newly installed manufacturing facilities. Alongside this milestone, the company has secured new orders valued at Rs. 27 Crores. The dual announcement highlights both capacity expansion and fresh revenue inflows. This is a positive operational update signalling growth momentum for the company.
Positive for shareholders — new capacity is now revenue-generating, and the Rs. 27 Crore order book boost could support top-line growth in upcoming quarters. May attract short-term buying interest from investors tracking capacity and order wins.